rs34491125

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032776.3(JMJD1C):​c.7200C>G​(p.Asp2400Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0303 in 1,613,314 control chromosomes in the GnomAD database, including 995 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 66 hom., cov: 32)
Exomes 𝑓: 0.031 ( 929 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.71

Publications

13 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031909347).
BP6
Variant 10-63177741-G-C is Benign according to our data. Variant chr10-63177741-G-C is described in ClinVar as Benign. ClinVar VariationId is 460277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0577 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.7200C>G p.Asp2400Glu missense_variant Exon 23 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.7200C>G p.Asp2400Glu missense_variant Exon 23 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1
JMJD1CENST00000542921.5 linkc.6654C>G p.Asp2218Glu missense_variant Exon 22 of 25 1 ENSP00000444682.1 Q15652-3
JMJD1CENST00000402544.5 linkn.6916C>G non_coding_transcript_exon_variant Exon 19 of 22 1
JMJD1CENST00000327520.7 linkc.2838C>G p.Asp946Glu missense_variant Exon 12 of 12 2 ENSP00000335929.5 H7BXU7

Frequencies

GnomAD3 genomes
AF:
0.0245
AC:
3734
AN:
152144
Hom.:
67
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00685
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.0310
Gnomad ASJ
AF:
0.0896
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0631
Gnomad FIN
AF:
0.00490
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0312
Gnomad OTH
AF:
0.0373
GnomAD2 exomes
AF:
0.0286
AC:
7128
AN:
249382
AF XY:
0.0320
show subpopulations
Gnomad AFR exome
AF:
0.00549
Gnomad AMR exome
AF:
0.0154
Gnomad ASJ exome
AF:
0.0858
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.00742
Gnomad NFE exome
AF:
0.0287
Gnomad OTH exome
AF:
0.0334
GnomAD4 exome
AF:
0.0309
AC:
45165
AN:
1461052
Hom.:
929
Cov.:
31
AF XY:
0.0325
AC XY:
23586
AN XY:
726838
show subpopulations
African (AFR)
AF:
0.00651
AC:
218
AN:
33474
American (AMR)
AF:
0.0169
AC:
754
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0851
AC:
2222
AN:
26120
East Asian (EAS)
AF:
0.000176
AC:
7
AN:
39684
South Asian (SAS)
AF:
0.0676
AC:
5828
AN:
86210
European-Finnish (FIN)
AF:
0.00757
AC:
404
AN:
53400
Middle Eastern (MID)
AF:
0.0647
AC:
373
AN:
5762
European-Non Finnish (NFE)
AF:
0.0300
AC:
33331
AN:
1111328
Other (OTH)
AF:
0.0336
AC:
2028
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
2120
4240
6360
8480
10600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1282
2564
3846
5128
6410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0245
AC:
3732
AN:
152262
Hom.:
66
Cov.:
32
AF XY:
0.0245
AC XY:
1824
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00683
AC:
284
AN:
41554
American (AMR)
AF:
0.0309
AC:
472
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0896
AC:
311
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.0636
AC:
307
AN:
4830
European-Finnish (FIN)
AF:
0.00490
AC:
52
AN:
10602
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0312
AC:
2120
AN:
68006
Other (OTH)
AF:
0.0369
AC:
78
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
177
355
532
710
887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0327
Hom.:
88
Bravo
AF:
0.0241
TwinsUK
AF:
0.0324
AC:
120
ALSPAC
AF:
0.0319
AC:
123
ESP6500AA
AF:
0.00977
AC:
36
ESP6500EA
AF:
0.0326
AC:
267
ExAC
AF:
0.0284
AC:
3431
Asia WGS
AF:
0.0160
AC:
57
AN:
3478
EpiCase
AF:
0.0328
EpiControl
AF:
0.0320

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early myoclonic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.026
.;T;.
Eigen
Benign
-0.062
Eigen_PC
Benign
0.021
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.63
T;T;T
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.61
.;N;.
PhyloP100
1.7
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.1
.;N;N
REVEL
Benign
0.14
Sift
Benign
0.31
.;T;T
Sift4G
Benign
0.54
.;T;T
Polyphen
0.48
.;P;.
Vest4
0.11, 0.18
MutPred
0.38
.;Loss of ubiquitination at K2397 (P = 0.0949);.;
MPC
1.3
ClinPred
0.013
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.18
gMVP
0.61
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34491125; hg19: chr10-64937501; COSMIC: COSV59514358; COSMIC: COSV59514358; API